| [1] |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315(8):801–810.
|
| [2] |
李真玉, 陈兵. 脓毒症心肌抑制的诊治进展. 中国循环杂志, 2015, 30(7):705–707.
|
| [3] |
Cunnion RE, Schaer GK, Parker MM, et al. The coronary circulation in human septic shock[J]. Circulation, 1986, 73(4):637–644.
|
| [4] |
Vieillard-Baron A. Septic cardiomyopathy[J]. Ann Intensive Care, 2011, 1(1):6.
|
| [5] |
Kakihana Y, Ito T, Nakahara M, et al. Sepsis-induced myocardial dysfunction: pathophysiology and management[J]. J Intensive Care, 2016, 4(1):22.
|
| [6] |
Pathan N, Franklin JL, Eleftherohorinou H, et a1. Myocardial depressant effects of interleukin 6 in meningococcal sepsis are regulated by p38 mitogen-activated protein kinase[J]. Crit Care Med, 2011, 39(7):1692–1711.
|
| [7] |
Barth E, Radermacher P, Thiemermann C, et al. Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock[J]. Crit Care Med, 2006, 34(2):307–313.
|
| [8] |
李莉, 严静, 陈昌勤, 等. 线粒体损伤在脓毒症大鼠心肌细胞凋亡中的作用[J]. 中华急诊医学杂志, 2012, 21(11):1221–1225.
|
| [9] |
HobaiI A, Edgecomb J, LaBarge K, et a1. Dysregulation of intracellular calcium transporters in animal models of sepsis induced cardiomyopathy[J]. Shock, 2015, 43(1):3–15.
|
| [10] |
MacKenzie A. Endothelium-derived vasoactive agents, AT1 receptors and inflammation[J]. Pharmacol Ther, 2011, 131(2):187–203.
|
| [11] |
Salgado DR, Rocco JR, Silva E, et a1. Modulation of the reninangiotensin-aldosterone system in sepsis: a new therapeutic approach[J]? Expert Opin Ther Targets, 2010, 14(1):11–20.
|
| [12] |
Jabot J, Monnet X, Bouchra L, et al. Cardiac function index provided by transpulmonary thermodilution behaves as an indicator of left ventricular systolic function[J]. Crit Care Med, 2009, 37(11):2913–2918.
|
| [13] |
Wang J, Ji W, Xu Z, et al. Clinical significance of plasma levels of brain natriuretic peptide and cardiac troponin T in patients with sepsis[J]. Exp Ther Med, 2016, 11(1):154–156.
|
| [14] |
Parker MM, McCarthy KE, Ognibene FP, et al. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans[J]. Chest, 1990, 97(1):126–131.
|
| [15] |
Bouhemad B, Nicolas RA, Arbelot C, et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction[J]. Crit Care Med, 2009, 37(2):441–447.
|
| [16] |
Røsjø H, Varpula M, Hagve TA, et al. The FINNSEPSIS Study Group. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome[J]. Intensive Care Med, 2011, 37(1):77–85.
|
| [17] |
Lorigados CB, Soriano FG, Szabo C. Pathomeehanisms of myocardial dysfunction in sepsis[J]. Endocr Metab Immune Disord Drug Targets, 2010, 10(3):274–284.
|
| [18] |
Merx MW, Weber C. Sepsis and the heart[J]. Circulation, 2007, 116(7):793–802.
|
| [19] |
Kalbitz M, Grailer JJ, Fattahi F, et al. Role of extracellular histones in the cardiomyopathy of sepsis[J]. FASEB J, 2015, 29(5):2185–2193.
|
| [20] |
Alhamdi Y, Abrams ST, Cheng Z, et al. Circulating histones are major mediators of cardiac injury in patients with sepsis[J]. Crit Care Med, 2015.43(10):2094–2103.
|
| [21] |
Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography[J]. Eur J Echocardiogr, 2009, 10(2):165–193.
|
| [22] |
Ng PY, Sin WC, Ng AK, et al. Speckle tracking echocardiography in patients with septic shock: a case control study (SPECKSS)[J]. Crit Care, 2016, 20(1):145.
|
| [23] |
Delphine H, Martin K, Julien N, et al. Comparison of real-time three dimensional speckle tracking to magnetic resonance imaging in patients with coronary heart disease[J]. Am J Cardiol, 2012, 109(2):180–186.
|
| [24] |
Parker MM, Shelhamer JH, Bacharach SL, et al. Profound but reversible myocardial depression in patients with septic shock[J]. Ann Intern Med, 1984, 100(4):483–490.
|
| [25] |
Jardin F, Brun-Ney D, Auvert B, et al. Sepsis-related cardiogenic shock[J]. Crit Care Med, 1990, 18(10):1055–1060.
|
| [26] |
Repessé X, Charron C, Vieillard BA. Evaluation of left ventricular systolic function revisited in septic shock[J]. Crit Care, 2013, 17(4):164–167.
|
| [27] |
Bouhemad B, Nicolas RA, Arbelot C, et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction[J]. Crit Care Med, 2009, 37(2):441–447.
|
| [28] |
Landesberg G, Gilon D, Meroz Y, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock[J]. Eur Heart J, 2012, 33(7):895–903.
|
| [29] |
Bouhemad B, Nicolas-Robin A, Arbelot C, et al. Isolated and reversible impairment of ventricular relaxation in patients with septic shock[J]. Crit Care Med, 2008, 36(3):766–774.
|
| [30] |
Kimchi A, Ellrodt AG, Berman DS, et al. Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study[J]. J Am Coll Cardiol, 1984, 4(5):945–951.
|
| [31] |
Hogue B, Chagnon F, Lesur O. Resuscitation fluids and endotoxin-induced myocardial dysfunction: is selection a load-independent differential issue[J]? Shock, 2012, 38(3):307–313.
|
| [32] |
Morelli A, De Castro S, Teboul JL, et a1. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression[J]. Intensive Care Med, 2005, 31(5):638–644.
|
| [33] |
Avgeropoulou C, Andreadou I, Markantonis KS, et al. The Ca-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine[J]. Eur J Heart Fail, 2005, 7(5):882–887.
|
| [34] |
Hamzaoui O, Georger JF, Monnet x, et a1. Early administration of norepinephrine increases cardiac preload and cardiac 0utput in septic patients with life-threatening hypotension[J]. Crit Care, 2010, 14(4):R142.
|
| [35] |
De Backer D, Aldecoa C, Njimi H, et al. Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis[J]. Crit Care Med, 2012, 40(3):725–730.
|
| [36] |
Dellinger RP, Levy MM, Rhodes A, et a1. Surviving sepsis Campaign: international guidelines for management of severe sepsis and septic shock2012[J]. Intensive Care Med, 2013, 39(2):165–228.
|
| [37] |
Solomon SB, Minneci PC, Deans KJ, et al. Effects of intra-aortic balloon counterpulsation in a model of septic shock[J]. Crit Care Med, 2009, 37(1):7–18.
|
| [38] |
郭炜, 盛博, 赵磊, 等. 主动脉球囊反搏术在感染性休克患者抢救治疗中的应用价值. 中国危重病急救医学, 2012, 24(1):46–49.
|
| [39] |
Pořízka M, Kopecký P, Prskavec T, et al. Successful use of extra-corporeal membrane oxygenation in a patient with streptococcal sepsis: a case report and review of literature[J]. Prague Med Rep, 2015, 116(1):57–63.
|
| [40] |
Fujisaki N, Takahashi A, Arima T, et al. Successful treatment of panton-valentine leukocidin-expressing Staphylococcus aureus-associated pneumonia co-infected with influenza using extracorporeal membrane oxygenation[J]. In Vivo, 2014, 28(5):961–965.
|